Form 483

KL Distributing Form 483, 2022-10-27

FDA issued a Form 483 to KL Distributing on 2022-10-27 with 24 public-safe observations.

483· Form 483 issuedMedical Devices & Rad Health24 observations

KL Distributing · Hudson, United States · Issued October 27, 2022

Overview

  • 24 public-safe observations are available for this inspection.
  • 6 structured CFR citations are represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

27 Oct 2022
21 CFR 803.17

Lack of Written MDR Procedures

Cited by Stanley B Eugene

27 Oct 2022
21 CFR 803.17

Lack of Written MDR Procedures

Cited by Stanley B Eugene

27 Oct 2022
21 CFR 820.20(a)

Management ensuring quality policy is understood

Cited by Stanley B Eugene

27 Oct 2022
21 CFR 820.20(a)

Management ensuring quality policy is understood

Cited by Stanley B Eugene

27 Oct 2022
21 CFR 820.20(b)(3)

Management representative

Cited by Stanley B Eugene

Inspected site

KDKL DistributingHudson, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 803.17Cited across public-safe Form 483 observations4x
21 CFR 820.20(a)Cited across public-safe Form 483 observations4x
21 CFR 820.20(b)(3)Cited across public-safe Form 483 observations4x
21 CFR 820.25(b)Cited across public-safe Form 483 observations4x
21 CFR 820.40Cited across public-safe Form 483 observations4x
21 CFR 820.50Cited across public-safe Form 483 observations4x

Source document

PDF
PDF available

Form 483 source document

The source document is available to authorized Atlas users.

Full 483 report

Get the verbatim text of all 24 observations

The source PDF, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere